{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:40:27Z","timestamp":1793072427559,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/26\/2019\/NCD-III"],"award-info":[{"award-number":["5\/13\/26\/2019\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115634","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:24:19Z","timestamp":1760804659000},"page":"115634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["HDAC6 inhibition attenuates RIPK1\/RIPK3\/MLKL signalling and improves anti-tumor immune response in oral cancer"],"prefix":"10.1016","volume":"167","author":[{"given":"Ashutosh","family":"Mahale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Regula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesha","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onkar Prakash","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0005","first-page":"3","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","volume":"24","author":"Clucas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115634_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/imr.12583","article-title":"Necroptotic cell death in anti-cancer therapy","volume":"280","author":"Krysko","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2025.115634_bb0020","article-title":"Examination of the role of necroptotic damage-associated molecular patterns in tissue fibrosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115634_bb0025","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s12276-022-00868-z","article-title":"Roles of RIPK3 in necroptosis, cell signaling, and disease","volume":"54","author":"Morgan","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115634_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation","volume":"11","author":"Duan","year":"2020","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.intimp.2025.115634_bb0035","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.3390\/ijms251910760","article-title":"Induced necroptosis and its role in cancer immunotherapy","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.115634_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/BCJ20210604","article-title":"Regulation of the release of damage-associated molecular patterns from necroptotic cells","volume":"479","author":"Nakano","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2025.115634_bb0045","article-title":"RETRA induces necroptosis in cervical cancer cells through RIPK1, RIPK3, MLKL and increased ROS production","volume":"922","author":"Mohanty","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115634_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-018-0976-z","article-title":"Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia","volume":"37","author":"Huang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115634_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tips.2016.12.005","article-title":"Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis","volume":"38","author":"Saleh","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2025.115634_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.16","article-title":"Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death","volume":"6","author":"Moriwaki","year":"2015","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2025.115634_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108919","article-title":"HDAC6 inhibition attenuates renal injury by reducing IL-1\u03b2 secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy","volume":"110","author":"Sedmaki","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115634_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111921","article-title":"Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1\u03b2 and modulating immunosuppressive response in OSCC","volume":"132","author":"Mahale","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115634_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70008","article-title":"Necrostatin-1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice","volume":"39","author":"Saravanan","year":"2025","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115634_bb0085","first-page":"1324915","article-title":"Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115634_bb0090","article-title":"High RIPK1\/RIPK3\/MLKL expression correlates with poor survival and OSCC progression","volume":"189","author":"Huang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115634_bb0095","first-page":"4823","article-title":"Crosstalk between necroptosis and other death pathways in cancer","volume":"78","author":"Liu","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115634_bb0100","first-page":"412","article-title":"Apoptosis, necroptosis, and autophagy: interplay in OSCC progression and treatment resistance","volume":"16","author":"Zhu","year":"2022","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115634_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115634_bb0110","first-page":"267","article-title":"Necroptosis and tumor immune escape: mechanisms and therapeutic strategies","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115634_bb0115","article-title":"Targeting necroptotic signaling in cancer therapy: opportunities and challenges","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115634_bb0120","article-title":"RETRA induces necroptosis in cervical cancer cells via RIPK1\/RIPK3\/MLKL and ROS","volume":"922","author":"Mohanty","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115634_bb0125","first-page":"452","article-title":"RIPK3 and MLKL inhibition suppresses oral squamous cell carcinoma cell viability","volume":"12","author":"Li","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.115634_bb0130","article-title":"Synergistic inhibition of necroptosis and chemotherapy enhances therapeutic efficacy in OSCC","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115634_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.intimp.2025.115634_bb0140","first-page":"1164","article-title":"RIPK1 inhibitor necrostatin-1 attenuates kidney injury by downregulating TGF-\u03b21 and pro-inflammatory cytokines","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0145","first-page":"13","article-title":"Necrosome activation downstream of TGF-\u03b2 signaling drives fibroblast activation and ECM accumulation","volume":"15","author":"Imamura","year":"2022","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.intimp.2025.115634_bb0150","article-title":"MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking","volume":"7","author":"Yoon","year":"2016","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.115634_bb0155","first-page":"jcs260013","article-title":"Microtubule disruption impairs MLKL translocation and necroptotic signaling","volume":"136","author":"Feng","year":"2023","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115634_bb0165","first-page":"384","article-title":"HDAC6 modulates tubulin acetylation and regulates necroptotic transport in cancer","volume":"8","author":"Jochems","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2025.115634_bb0170","first-page":"21","article-title":"HDAC6 modulates MLKL trafficking via microtubule dynamics","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.intimp.2025.115634_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.intimp.2025.115634_bb0180","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"6230","key":"10.1016\/j.intimp.2025.115634_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2025.115634_bb0190","first-page":"3","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","volume":"24","author":"Clucas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.115634_bb0195","first-page":"1122349","article-title":"PMN-MDSCs contribute to cancer immunotherapy resistance","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115634_bb0200","first-page":"223","article-title":"The tumor microenvironment: dynamic macrophage polarization and cancer progression","volume":"20","author":"Liu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"7621","key":"10.1016\/j.intimp.2025.115634_bb0205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature19364","article-title":"Ionic immune suppression within the tumor microenvironment limits T cell effector function","volume":"537","author":"Eil","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2025.115634_bb0210","article-title":"NecroScore correlates with immune cell infiltration and checkpoint expression in cancer","volume":"10","author":"Xie","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2025.115634_bb0215","first-page":"5536","article-title":"IFN-\u03b3 orchestrates anti-tumor immune responses through CD8+ T cells","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.intimp.2025.115634_bb0220","first-page":"3723","article-title":"Granzyme a degrades RIPK3 and inhibits necroptosis","volume":"30","author":"Lawlor","year":"2020","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.115634_bb0225","first-page":"1353","article-title":"Granzyme-mediated immune evasion by cancer cells through necroptosis suppression","volume":"129","author":"Sarhan","year":"2019","journal-title":"J. Clin. Investig."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501625X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501625X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:59:05Z","timestamp":1778619545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692501625X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S156757692501625X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115634","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC6 inhibition attenuates RIPK1\/RIPK3\/MLKL signalling and improves anti-tumor immune response in oral cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115634"}}